This is the authors' abstract. We don't add key points for this paper.
A device for continuous in vivo monitoring of glucose concentration in people with diabetes has been a clinical and research priority for many years but now has an urgency which is probably unquestioned in diabetes care. The purpose of this article is to explain recent advances in technology that are bringing glucose sensors closer to routine use and to highlight some of the remaining problems. Important new technologies include artificial receptors for glucose, tissue fluid sampling techniques, and new approaches to non-invasive sensing, such as fluorescence lifetime measurements.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Pickup et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: